201 related articles for article (PubMed ID: 23583521)
21. Expression of Caveolin-1 reduces cellular responses to TGF-beta1 through down-regulating the expression of TGF-beta type II receptor gene in NIH3T3 fibroblast cells.
Lee EK; Lee YS; Han IO; Park SH
Biochem Biophys Res Commun; 2007 Jul; 359(2):385-90. PubMed ID: 17543885
[TBL] [Abstract][Full Text] [Related]
22. Human xylosyltransferase-I - a new marker for myofibroblast differentiation in skin fibrosis.
Faust I; Roch C; Kuhn J; Prante C; Knabbe C; Hendig D
Biochem Biophys Res Commun; 2013 Jul; 436(3):449-54. PubMed ID: 23747722
[TBL] [Abstract][Full Text] [Related]
23. Idiopathic pulmonary fibrosis--new insights.
Verma S; Slutsky AS
N Engl J Med; 2007 Mar; 356(13):1370-2. PubMed ID: 17392309
[No Abstract] [Full Text] [Related]
24. Enhanced deposition of cartilage oligomeric matrix protein is a common feature in fibrotic skin pathologies.
Agarwal P; Schulz JN; Blumbach K; Andreasson K; Heinegård D; Paulsson M; Mauch C; Eming SA; Eckes B; Krieg T
Matrix Biol; 2013 Aug; 32(6):325-31. PubMed ID: 23507196
[TBL] [Abstract][Full Text] [Related]
25. Caveolin-1, transforming growth factor-beta receptor internalization, and the pathogenesis of systemic sclerosis.
Del Galdo F; Lisanti MP; Jimenez SA
Curr Opin Rheumatol; 2008 Nov; 20(6):713-9. PubMed ID: 18949888
[TBL] [Abstract][Full Text] [Related]
26. Involvement of caveolin-1 in fibronectin-induced mouse embryonic stem cell proliferation: role of FAK, RhoA, PI3K/Akt, and ERK 1/2 pathways.
Park JH; Ryu JM; Han HJ
J Cell Physiol; 2011 Jan; 226(1):267-75. PubMed ID: 20658539
[TBL] [Abstract][Full Text] [Related]
27. Hyaluronan's Role in Fibrosis: A Pathogenic Factor or a Passive Player?
Albeiroti S; Soroosh A; de la Motte CA
Biomed Res Int; 2015; 2015():790203. PubMed ID: 26583132
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-7 modulates extracellular matrix production and TGF-beta signaling in cultured human subconjunctival fibroblasts.
Yamanaka O; Saika S; Ikeda K; Miyazaki K; Ohnishi Y; Ooshima A
Curr Eye Res; 2006 Jun; 31(6):491-9. PubMed ID: 16769608
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells.
Morales MG; Vazquez Y; Acuña MJ; Rivera JC; Simon F; Salas JD; Alvarez Ruf J; Brandan E; Cabello-Verrugio C
Int J Biochem Cell Biol; 2012 Nov; 44(11):1993-2002. PubMed ID: 22964022
[TBL] [Abstract][Full Text] [Related]
30. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
31. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442
[TBL] [Abstract][Full Text] [Related]
32. Renin is an angiotensin-independent profibrotic mediator: role in pulmonary fibrosis.
Montes E; Ruiz V; Checa M; Maldonado V; Melendez-Zajgla J; Montaño M; Ordoñez-Razo R; Cisneros J; García-de-Alba C; Pardo A; Selman M
Eur Respir J; 2012 Jan; 39(1):141-8. PubMed ID: 21659414
[TBL] [Abstract][Full Text] [Related]
33. Augmented cytoplasmic Smad4 induces acceleration of TGF-beta1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation.
Goto Y; Manabe N; Uchio-Yamada K; Yamaguchi-Yamada M; Inoue N; Yamamoto Y; Ogura A; Nagano N; Miyamoto H
Cell Tissue Res; 2004 Feb; 315(2):209-21. PubMed ID: 14615933
[TBL] [Abstract][Full Text] [Related]
34. Dupuytren's Disease Is Mediated by Insufficient TGF-β1 Release and Degradation.
Oezel L; Wohltmann M; Gondorf N; Wille J; Güven I; Windolf J; Thelen S; Jaekel C; Grotheer V
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894778
[TBL] [Abstract][Full Text] [Related]
35. Decreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5.
Yamaguchi Y; Yasuoka H; Stolz DB; Feghali-Bostwick CA
J Cell Mol Med; 2011 Apr; 15(4):957-69. PubMed ID: 20345844
[TBL] [Abstract][Full Text] [Related]
36. Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis.
Hinz B
Curr Rheumatol Rep; 2009 Apr; 11(2):120-6. PubMed ID: 19296884
[TBL] [Abstract][Full Text] [Related]
37. The extracellular matrix and transforming growth factor-β1: Tale of a strained relationship.
Hinz B
Matrix Biol; 2015 Sep; 47():54-65. PubMed ID: 25960420
[TBL] [Abstract][Full Text] [Related]
38. Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis.
Xia H; Khalil W; Kahm J; Jessurun J; Kleidon J; Henke CA
Am J Pathol; 2010 Jun; 176(6):2626-37. PubMed ID: 20395445
[TBL] [Abstract][Full Text] [Related]
39. Profibrogenic phenotype in caveolin-1 deficiency via differential regulation of STAT-1/3 proteins.
Ryter SW; Choi AM; Kim HP
Biochem Cell Biol; 2014 Oct; 92(5):370-8. PubMed ID: 25263949
[TBL] [Abstract][Full Text] [Related]
40. Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms.
Sotgia F; Martinez-Outschoorn UE; Howell A; Pestell RG; Pavlides S; Lisanti MP
Annu Rev Pathol; 2012; 7():423-67. PubMed ID: 22077552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
